Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Related Articles by Review for PubMed (Select 20345708)

1.

Effect of the small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor, PAI-749, in clinical models of fibrinolysis.

Lucking AJ, Visvanathan A, Philippou H, Fraser S, Grant PJ, Connolly TM, Gardell SJ, Feuerstein GZ, Fox KA, Booth NA, Newby DE.

J Thromb Haemost. 2010 Jun;8(6):1333-9. doi: 10.1111/j.1538-7836.2010.03872.x. Epub 2010 Mar 25.

PMID:
20345708
2.

Recombinant plasminogen activator inhibitor type 1: a review of structural, functional, and biological aspects.

Reilly TM, Mousa SA, Seetharam R, Racanelli AL.

Blood Coagul Fibrinolysis. 1994 Feb;5(1):73-81. Review.

PMID:
8180342
3.

Therapeutic potential of plasminogen activator inhibitor-1 inhibitors.

Brown NJ.

Ther Adv Cardiovasc Dis. 2010 Oct;4(5):315-24. doi: 10.1177/1753944710379126. Epub 2010 Jul 26. Review.

PMID:
20660535
4.

Inhibition of PAI-1: a new anti-thrombotic approach.

Wu Q, Zhao Z.

Curr Drug Targets Cardiovasc Haematol Disord. 2002 Jun;2(1):27-42. Review.

PMID:
12769655
5.

Plasminogen activator inhibitor-1.

Gils A, Declerck PJ.

Curr Med Chem. 2004 Sep;11(17):2323-34. Review.

PMID:
15379715
7.

Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.

Rerolle JP, Hertig A, Nguyen G, Sraer JD, Rondeau EP.

Kidney Int. 2000 Nov;58(5):1841-50. Review.

8.

Plasminogen activator inhibitor-1 in the pathogenesis of asthma.

Cho SH, Ryu CH, Oh CK.

Exp Biol Med (Maywood). 2004 Feb;229(2):138-46. Review.

PMID:
14734792
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk